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| INTRODUC TI ON
Previous studies showed that GCs induced anti-inflammatory monocyte subsets with a high migratory capacity in mice and humans, [2] [3] [4] which are similar to tumor-induced myeloid-derived suppressor cells (MDSCs). 5 Although MDSCs were first identified and well-characterized in tumors, [6] [7] [8] recent evidence demonstrates that
MDSCs play an important role in the regulation of immune responses in many pathologic conditions such as infection, autoimmune diseases, or transplantation.
5,8-10
Based on these findings, we hypothesized that MDSCs might be involved in the GC-mediated tolerance in transplantation. To test this hypothesis, we investigated whether (1) systemic administration of GCs induces MDSCs in mice with corneal allografts, and (2) MDSCs mediate the action of GCs in tolerance induction to the allografts.
| MATERIAL S AND ME THODS

| Animal model of corneal transplantation
The experimental protocols were approved by the Institutional Animal Care and Use Committee of Seoul National University
Hospital.
Eight-week-old male B6 mice (H- proparacaine hydrochloride, Hanmi Pharm., Seoul, Korea) was applied to the cornea prior to surgery.
For surgery, a central 2.5-mm diameter corneal button was excised from a donor mouse using a trephine (Katena Products, Inc., Denville, NJ), and recipient corneal bed was prepared by removal of a central 2-mm diameter button in a recipient mouse. The donor button was secured to the recipient bed with five interrupted 10-0 nylon sutures. The suture knots were cut as short as possible and not removed during the follow-up.
For treatment, dexamethasone (Dex)(DAEWON Pharm., Seoul, Korea) was intraperitoneally administered into recipient mice daily from day 0 (the day of surgery) to 21 (21 days after transplantation).
For the first week, mice received 5 mg/kg bodyweight Dex, and the dose was tapered to 3 mg/kg for the second week and to 1 mg/kg for the third. In control mice, the same volume of phosphate-buffered solution (PBS) was administered in the same manner.
Corneal grafts were clinically observed twice a week under slitlamp biomicroscopy. Corneas were evaluated based on the opacification scoring system (scale of 0-4), 11 where score 0 = no opacity; score 1 = mild opacity, iris details visible; score 2 = moderate opacity, pupillary margin visible, iris details invisible; score 3 = significant opacity, pupillary margin invisible; and score 4 = completely opaque, pupil and anterior chamber not visible. The graft rejection was defined as complete loss of graft transparency (score 4).
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On days 1, 7, 21, 28, 42, and 56, mice were euthanized. The cornea, draining cervical lymph nodes (CLNs), peripheral blood, spleen, and bone marrow (BM) were extracted.
| Histology
The excised corneas were fixed in 10% formaldehyde and embedded in paraffin. Serial 4-µm thick cross-sections were made for hematoxy- 
| Real-time RT PCR
The tissues were lysed in RNA isolation reagent (RNA-Bee, Tel-Test 
| Flow cytometry
To obtain single cell suspension, the cornea was treated with 1 mg/ mL collagenase type I (Worthington, Lakewood, NJ) for 30 minute at 
| Giemsa staining
The cells were collected on microscopic slides by cytospin and stained with Giemsa solution (GS-500, Sigma-Aldrich, St. Louis, MO).
| In vivo cell depletion
For depletion of CD11b + Ly6C + cells, 100 μg anti-mouse Gr-1 monoclonal antibody (clone RB6-8C5, BioXCell, West Lebanon, NH) or rat IgG2b isotype control (clone LTF-2, BioXCell) was intraperitoneally injected into mice twice weekly for the first 21 days posttransplantation simultaneously with Dex treatment. The efficiency of cell depletion was confirmed by flow cytometry. 
| Adoptive transfer
| Statistical analysis
The two-tailed Student's t test was used to compare the means of two groups (GraphPad Prism, Inc., La Jolla, CA). One-way ANOVA and Tukey's honestly significant difference test were used for comparisons among more than two groups. The Kaplan-Meier method was applied to evaluate the overall cumulative probability of graft survival, and the Breslow (generalized Wilcoxon) test was used to compare the graft survival between groups. A value of P < .05 was considered to be significant.
| RE SULTS
| GCs induce corneal allograft tolerance
We confirmed the effects of systemic GC administration on corneal allografts. As shown in Figure 1A , Dex or PBS was F I G U R E 1 Systemic administration of glucocorticoids prolonged corneal allograft survival and prevented immune rejection. A, Experimental scheme. Corneal allogeneic transplantation (Allo, B6 to BALB/c) or syngeneic transplantation (Auto, BALB/c to BALB/c) was performed on day 0, and glucocorticoids (GC) were daily injected into the peritoneal cavity for 21 consecutive days. In the control group, phosphate-buffered solution (PBS) was administered in the same manner. The grafts were clinically observed, and the cornea, cervical draining lymph nodes (CLN), peripheral blood, spleen, and bone marrow (BM) were extracted on days 1, 7, 21, 28, 42, and 56 after transplantation. isolated from five individual mice were, respectively, used in one set of coculture experiment, and a total three sets of experiments were performed independently. Data are presented as mean + SD and represent three independent experiments. ns: not significant, ***P < .001, ****P < .0001 [Color figure can be viewed at wileyonlinelibrary.com] in the spleen, blood, CLNs, and corneal grafts in Dex-treated mice from day 21 to 28 of transplantation ( Figure 2B,C) . Given that corneal allograft rejection started from day 21 ( Figure 1B,F Figure 2C ). In agreement with MHC II − CD11b + Ly6C + cell accumulation, the mRNA level of iNOS, a nitric oxide-producing metabolic enzyme, was increased in CLNs and allografts in Dex-treated mice ( Figure 2D ).
We additionally analyzed for CD4 + Foxp3 + regulatory T cells (Tregs), but Dex did not induce Tregs at any time-points ( Figure S2 ). Figure 3C ). Figure 3A and transferred into GC-untreated mice on days 21 and 24 posttransplantation. Ten mice were used to obtain CD11b + Ly6C Figure S3 ). animal. F, Survival curve of corneal allografts and corneal opacity scores over time posttransplantation. G, Immunostaining for CD3 (original magnification × 100) and MHC class II (red) and CD11b (green) (scale bar 50 μm) in corneal cross-sections. DAPI for nuclear counterstaining (blue). Data are presented as mean +/±SD. ns: not significant, *P < .05, **P < .01, ***P < .001, ****P < .0001
| GC-induced CD11b
Collectively, data indicate that GC-induced CD11b + Ly6C + monocytes exhibited immunosuppressive activities both in vitro and in vivo. Based on the expression of phenotypic markers CD11b and Ly6C ( Figure 2 ) and T cell-suppressive functions (Figures 3, 4 As is well-known, various mechanisms are involved in the immunosuppressive activities of GCs. In the present study, we used a model of low-risk corneal allotransplantation in naïve mice, where rejection is mainly mediated by T cell activation via indirect pathway. 22 Our study has two clinical implications. First, according to our time-course analysis, MDSCs started to increase in BM after 7 days of GC administration. Thus, our finding favors the notion that early treatment with GCs is important for promotion of allograft survival. 23 Although we did not evaluate the effects of locally applied GCs, it is likely that systemic infusion of GCs is more effective at inducing MDSC expansion in BM, given the level of GCs in BM after systemic versus local administration. Second, our data suggest that monocytic MDSCs might be a potential cellular source for tolerogenic cell therapy in transplantation. Future investigation into molecular mechanisms by which GCs induce MDSC expansion would allow for the effective and safe application of the cells in the clinic. 
| D ISCUSS I ON
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